There has been a pretty significant increase in RSV over the past month. Yes, we're trying to make it as fast and convenient for the doctor, or nurse, or whoever is doing the swab as possible.

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

Medically reviewed by Susan Russell, MDMedically reviewed by Susan Russell, MD Respiratory syncytial virus (RSV) is a common, contagious, respiratory infection that can affect people of all ages.

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

It often mimics the common cold, but RSV can quickly turn into bronchiolitis and pneumonia. “The older you get, the milder ...

Everyone age 60 and older who is at risk for getting very sick from RSV can get vaccinated, after talking with their doctor. Everyone age 60 and older who is at risk for getting very sick from RSV can ...

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

In adults 60 and over, vaccine effectiveness from October 2023 to March 2024 against RSV-associated hospitalization reached ...

By Lauren Pelley, CBC News, RCI Provinces taking different approaches, many Canadians may be paying out of pocket Respiratory syncytial virus, or RSV (new window), isn’t always top of mind during the ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

With the NHS kicking off its rollout of the Respiratory Syncytial Virus (RSV), this adds to the list of jabs available to help us get through the winter, such as flu and COVID-19. Pregnant women ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...